Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 23 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/1/1994


1.		Phase III Randomized, Double-Blind Study of Macrophage Colony-Stimulating Factor vs Placebo, Each with Standard Amphotericin-B Therapy, in Cancer Patients with Definitive or Probable Invasive Candidiasis (Summary Last Modified 06/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				3 and over								EORTC-19922

Last Modified: 11/1/1995


2.		Phase III Randomized, Double-Blind Study of Liposomal Amphotericin B vs Standard Formulation Amphotericin B for Empiric Treatment of Persistent Febrile Neutropenia Unresponsive to Broad Spectrum Antibacterial Agents (Summary Last Modified 11/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				2 to 80				NCI				NCI-95-C-0131A

Last Modified: 7/11/2007


3.		Phase III Randomized Study of Liposomal Nystatin vs Standard Amphotericin B for Empiric Treatment of Persistent Febrile Neutropenic Patients (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				2 and over				Pharmaceutical / Industry				AR-95-41.356-006 NCI-V96-0845, NCT00002742

Last Modified: 5/14/2007 First Published: 7/1/1997


4.		Phase III Randomized Study of Voriconazole vs Amphotericin B in Immunocompromised Patients With Acute Invasive Aspergillosis (Summary Last Modified 01/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				12 and over				Pharmaceutical / Industry				EORTC-19961 PFIZER-150-307-000, NCT00003031


5.		Phase III Study of Chemotherapy with ADR/CCNU/HMM/MTX and Amphotericin B for Advanced non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								CHNMC-COH-CA-LUN-1 NCI-D80-035-131


6.		Phase III Empirical Antimicrobial Therapy vs Early Open Lung Biopsy/Specific Therapy for Diffuse Interstitial Pneumonitis in Immunocompromised Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				no age specified								NCI-82-C-111


7.		Phase III Management and Prophylaxis of Fever and Infection with Antimicrobial Treatment in Cancer Patients (Study III)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				no age specified								NCI-81-C-189 NCI-POB-8103

Last Modified: 7/6/2007


8.		Phase III Maintenance Chemotherapy vs TBI/Marrow Transplant Following Conventional Induction and Consolidation for ANLL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-8124/25/26 SWOG-8124, SWOG-8125, SWOG-8126


9.		Phase III Amphotericin-B vs Amphotericin-B/Rifampin for Cancer Patients with Suspected Fungal Infections

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				no age specified								UMCC-7601


10.		Phase III MOX/AMK vs MOX/PIP for Suspected Infection in Febrile, Granulocytopenic Cancer Patients, with Amphotericin-B or Ketoconazole for Failures

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				no age specified								UMCC-8107

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute